Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, by Disease Type
1.4.2 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing
1.4.3 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Oct – 2021, Dec) Leading Players
Chapter 4. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type
4.1 Asia Pacific Chlamydia Market by Country
4.2 Asia Pacific Herpes simplex virus Market by Country
4.3 Asia Pacific Gonorrhea Market by Country
4.4 Asia Pacific Syphilis Market by Country
4.5 Asia Pacific Human papillomavirus (HPV) Market by Country
4.6 Asia Pacific Other Disease Market by Country
Chapter 5. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
5.1 Asia Pacific Laboratory Testing Market by Country
5.2 Asia Pacific Point of care (POC) Testing Market by Country
Chapter 6. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country
6.1 China Sexually Transmitted Diseases (STD) Testing Market
6.1.1 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.2 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2 Japan Sexually Transmitted Diseases (STD) Testing Market
6.2.1 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.2 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3 India Sexually Transmitted Diseases (STD) Testing Market
6.3.1 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.2 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4 South Korea Sexually Transmitted Diseases (STD) Testing Market
6.4.1 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.2 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.5 Singapore Sexually Transmitted Diseases (STD) Testing Market
6.5.1 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.5.2 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.6 Malaysia Sexually Transmitted Diseases (STD) Testing Market
6.6.1 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.6.2 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.7 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
6.7.1 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.7.2 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
Chapter 7. Company Profiles
7.1 BioMérieux S.A.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Hologic, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.7 DiaSorin Molecular LLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Danaher Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bio-Rad laboratories, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. OraSure Technologies, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional & Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
7.10.5.2 Acquisition and Mergers:
Unique Offerings 